Niagen Bioscience (NAGE) Capital Expenditures (2011 - 2026)
Niagen Bioscience (NAGE) reported Capital Expenditures of $61000.0 for Q1 2026, up 90.62% year-over-year from $32000.0 in Q1 2025, and down 39.6% quarter-over-quarter from $101000.0 in Q4 2025.
Niagen Bioscience (NAGE) Capital Expenditures (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 14 years of Capital Expenditures data on file, last reported at $61000.0 in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $61000.0, up 90.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $321000.0 (up 108.44% YoY), and the FY2025 annual result was $292000.0, up 79.14% from the prior year.
- Capital Expenditures eased to $61000.0 in Q1 2026 per NAGE's latest filing, from $101000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $172000.0 in Q4 2022 and troughed at $10000.0 in Q2 2023.
- A 5-year average of $58705.9 and a median of $41000.0 in 2024 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures soared 8500.0% in 2022, then slumped 88.24% in 2023.
- A 5-year view of Capital Expenditures shows it stood at $172000.0 in 2022, then slumped by 87.79% to $21000.0 in 2023, then jumped by 228.57% to $69000.0 in 2024, then jumped by 46.38% to $101000.0 in 2025, then plunged by 39.6% to $61000.0 in 2026.
- Business Quant data shows NAGE's Capital Expenditures at $61000.0 in Q1 2026, $101000.0 in Q4 2025, and $24000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -63,220.27 |
| 10 | Niagen Bioscience | 280.11 Mn | 213.56 Mn | 19.98 Mn | 61,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61,000.00 |
| Mar 31, 2026 | 61,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 135,000.00 |
| Jun 30, 2025 | 135,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 41,000.00 |
| Mar 31, 2024 | 41,000.00 |
| Dec 31, 2023 | 21,000.00 |
| Dec 31, 2023 | 21,000.00 |